Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Wed, 05/24/23 - 10:15 am
Tags:
Merck
,
vaccines
,
Gardasil
,
legal
,
HPV
,
side effects
Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic
Medical Xpress
Wed, 05/17/23 - 10:53 pm
Tags:
Merck
,
antibiotics
,
Recarbrio
,
FDA
,
BMJ
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
Tags:
M&A
,
antitrust
,
Amgen
,
Astellas
,
Bellus Health
,
Globus Medical
,
GSK
,
Horizon Therapeutics
,
Merck
,
NuVasive
,
Pfizer
,
Prometheus Biosciences
,
Seagen
Hummingbird and Merck to evaluate combination therapy for NSCLC
Clinical Trials Arena
Mon, 05/15/23 - 06:19 pm
Tags:
Merck
,
Hummingbird Bioscience
,
HMBD-001
,
cetuxumab
,
squamous non-small cell lung cancer
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Tags:
Gilead Sciences
,
GSK
,
momelotinib
,
Roche
,
Eli Lilly
,
lebrikizumab
,
Merck
,
Zejula
,
Amgen
,
Galenica
,
Veltassa
,
Cubicin
Gossamer cuts loose 25% of its staff, ties future to phase 3 trial of tarnished Merck rival
Fierce Biotech
Wed, 05/10/23 - 10:10 am
Tags:
Gossamer Bio
,
layoffs
,
seralutinib
,
Merck
,
PAH
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
Tags:
antibody-drug conjugate
,
Merck
,
Seagen
,
M&A
,
AstraZeneca
,
BioNTech
,
Bristol Myers Squibb
Merck bets big on PRA023 with $10.8bn Prometheus acquisition offer
Clinical Trials Arena
Wed, 05/3/23 - 10:37 pm
Tags:
Merck
,
Prometheus Biosciences
,
PRA023
,
ulcerative colitis
Merck entitled to $1.4B in cyberattack case after court rejects insurers' 'warlike action' claim
Fierce Pharma
Tue, 05/2/23 - 11:43 am
Tags:
Merck
,
legal
,
cybersecurity
,
cyberattacks
AbbVie, Bristol Myers vied for Prometheus before Merck bought it
Crain's Chicago Business
Mon, 05/1/23 - 10:15 pm
Tags:
Merck
,
Prometheus Biosciences
,
M&A
,
AbbVie
,
Bristol Myers Squibb
With negative FDA panel vote, AstraZeneca's Lynparza looks set for narrow nod in prostate cancer
Fierce Pharma
Mon, 05/1/23 - 10:16 am
Tags:
AstraZeneca
,
Merck
,
Lynparza
,
metastatic castration-resistant prostate cancer
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Reuters
Thu, 04/27/23 - 11:05 pm
Tags:
Merck
,
earnings
FDA Questions Efficacy of Merck-AstraZeneca’s Lynparza Ahead of Adcomm
BioSpace
Thu, 04/27/23 - 10:58 pm
Tags:
Merck
,
AstraZeneca
,
FDA
,
Lynparza
,
metastatic castration-resistant prostate cancer
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie
,
Amgen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sceinces
,
JNJ
,
Merck
,
Pfizer
,
Regeneron
,
patents
,
activists
Merck, Glenmark wrap up Zetia pay-for-delay case after pharmacies take settlement
Fierce Pharma
Tue, 04/25/23 - 10:05 pm
Tags:
Merck
,
Glenmark
,
Zetia
,
pay-for-delay
,
legal
In Zetia antitrust case, Merck and Glenmark ink deals with 2 plaintiff groups as retailers hold out
Fierce Pharma
Fri, 04/21/23 - 10:20 am
Tags:
Merck
,
Glenmark
,
Zetia
,
pay-for-delay
,
antitrust
,
legal
Moderna and Merck’s mRNA Cancer Vaccine Impresses but Experts Urge Caution
BioSpace
Fri, 04/21/23 - 10:10 am
Tags:
Moderna Therapeutics
,
Merck
,
MRNA
,
cancer vaccines
,
vaccines
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.